NHS Lothian Clinical Trials
Sponsors / NHS Lothian
ClinicalTrials.gov lists 155 trials for which NHS Lothian is named as lead sponsor. The portfolio currently includes 14 recruiting studies, 5 active non-recruiting studies, and 119 completed studies. 8 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include slow or insufficient recruitment, funding constraints. Cumulative planned enrollment across all listed trials is 1,210,769 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.
155
Total Trials
14
Recruiting
5
Other Active
119
Completed
8
Terminated / Withdrawn
1,210,769
Total Enrollment
Termination reasons: Other50% · Recruitment38% · Funding13%
Recent Terminations
- Hyperoxia"Failed to meet recruitment target"
- Obesity"Recruitment challenges"
- Lung Cancer"C-met marker expired"
- Abortion Early"Study suspended on 31 March 2020 due to COVID-19 pandemic. Aimed to restart study early 2021, but decision taken to formally terminate the study on 31st August 2021"
- Type 1 Diabetes"Unable to recruit participants due to lack of patients eligible at the time"
- Pain"Funding was terminated early due to slow recruitment."
- Hip Fractures"The Chief Investigator (John Keating)"
- Shoulder Dislocation
Active Trials (5 total)
- Motor Neuron Disease, Amyotrophic Lateral Sclerosis PHASE2/PHASE3NCT04302870
- NCT06604104
- NCT07364045
- NCT03502590
- NCT04081428
- NCT05366712
- NCT05290818
- NCT07398365
- NCT05518396
- NCT06117059
- NCT06557343
- NCT05642819
- NCT06698614
- NCT06450418
- NCT02833064
- NCT04406662
- NCT04829825
- NCT06800430
- NCT05588960